Edwards operated in 'secrecy' to stifle competition and subvert antitrust laws, US FTC argues
The US Federal Trade Commission argued in its proposed findings of fact and conclusions of law that Edwards Lifesciences operated in “secrecy” and designed its acquisitions of JenaValve and JC Medical...To view the full article, register now.
Already a subscriber? Click here to view full article